SEI INVESTMENTS CO - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$564,000
-16.7%
96,992
-14.5%
0.00%0.0%
Q2 2022$677,000
+2.9%
113,446
-19.5%
0.00%0.0%
Q1 2022$658,000–140,844–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders